X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (6) 6
female (5) 5
humans (5) 5
index medicus (5) 5
oncology (5) 5
breast neoplasms - pathology (4) 4
cancer (4) 4
hematology, oncology and palliative medicine (4) 4
metastasis (4) 4
middle aged (4) 4
aged (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
breast neoplasms - drug therapy (3) 3
cancer therapies (3) 3
care and treatment (3) 3
disease-free survival (3) 3
docetaxel (3) 3
oncology, experimental (3) 3
receptor, erbb-2 - analysis (3) 3
research (3) 3
adult (2) 2
analysis (2) 2
biography (2) 2
breast neoplasms - mortality (2) 2
capecitabine (2) 2
chemotherapy (2) 2
chemotherapy, adjuvant (2) 2
combination (2) 2
drug administration schedule (2) 2
her2 (2) 2
history (2) 2
intention to treat analysis (2) 2
lapatinib (2) 2
medical research (2) 2
neoplasm recurrence, local - drug therapy (2) 2
paclitaxel - administration & dosage (2) 2
product development (2) 2
proportional hazards models (2) 2
receptors, estrogen - analysis (2) 2
samaritans (2) 2
treatment outcome (2) 2
womens health (2) 2
1906-1999 (1) 1
1917-1963 (1) 1
acuarelistas (1) 1
adjuvant chemotherapy (1) 1
adjuvant treatment (1) 1
administration, oral (1) 1
age (1) 1
amplification (1) 1
animals (1) 1
anthracycline (1) 1
anthracyclines (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antigüedades (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antiquities (1) 1
antropofagia (1) 1
arameiska (1) 1
arkeologi: palestina (1) 1
aromatase inhibitors - administration & dosage (1) 1
arqueología social (1) 1
arthralgia (1) 1
astronomy & astrophysics (1) 1
aufsatzsammlung (1) 1
bevacizumab (1) 1
bibliography (1) 1
bibw 2992 (1) 1
biographie (1) 1
bioluminescence (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - genetics (1) 1
biometrics (1) 1
blood (1) 1
bone marrow (1) 1
breast neoplasms - chemistry (1) 1
breast neoplasms - enzymology (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - surgery (1) 1
breast neoplasms - therapy (1) 1
breast tumors (1) 1
breast-cancer (1) 1
cancer research (1) 1
cannibalism (1) 1
cannibalism congresses. southwest, new (1) 1
cardiovascular disease (1) 1
cell biology (1) 1
cell cycle (1) 1
cell-cycle (1) 1
cell-lines (1) 1
cells (1) 1
cleopatra (1) 1
clinical trials (1) 1
clinical-trials (1) 1
collaboration (1) 1
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Victoria University Emmanuel College - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 25 - 35
Summary Background Palbociclib (PD-0332991) is an oral, small-molecule inhibitor of cyclin-dependent kinases (CDKs) 4 and 6 with preclinical evidence of... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | EXEMESTANE | ONCOLOGY | CELL-CYCLE | POSTMENOPAUSAL WOMEN | HER2 | PLUS | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Triazoles - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Molecular Targeted Therapy | North America | Nitriles - administration & dosage | Breast Neoplasms - enzymology | Time Factors | Postmenopause | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Republic of Korea | Aromatase Inhibitors - administration & dosage | Pyridines - administration & dosage | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Europe | Proportional Hazards Models | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Treatment Outcome | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Cyclin D1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | South Africa | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Care and treatment | Oncology, Experimental | Estrogen | Breast cancer | Research | Antineoplastic agents | Phosphotransferases | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 755 - 769
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 357 - 366
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 4, pp. 369 - 376
Journal Article
Jerusalem Post, 01/2006
It needs to wake up and recognize what is happening in Jewish tourism, now commonly called "kosher tourism" today. In 2005 kosher tours, hotels and cruises... 
Newspaper Article
Jerusalem Post, 03/2007
Sir - In "We need unity more than a strike" (March 15), high school teacher David Graniewitz bemoans the ineffectiveness of the teachers' strike while having... 
Newspaper Article